PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,489,634 | -44.5% | 691,193 | +0.7% | 0.00% | -40.0% |
| Q2 2023 | $27,904,990 | -12.3% | 686,132 | +4.5% | 0.01% | -16.7% |
| Q1 2023 | $31,818,444 | +27.9% | 656,863 | +0.8% | 0.01% | +20.0% |
| Q4 2022 | $24,875,885 | -23.5% | 651,713 | +0.6% | 0.01% | -28.6% |
| Q3 2022 | $32,510,000 | +23.8% | 647,611 | -1.2% | 0.01% | +16.7% |
| Q2 2022 | $26,262,000 | +4.7% | 655,569 | -2.5% | 0.01% | +50.0% |
| Q1 2022 | $25,085,000 | -11.1% | 672,323 | -5.1% | 0.00% | -20.0% |
| Q4 2021 | $28,224,000 | +6.2% | 708,623 | -0.8% | 0.01% | 0.0% |
| Q3 2021 | $26,582,000 | -14.5% | 714,381 | -2.9% | 0.01% | 0.0% |
| Q2 2021 | $31,089,000 | -10.0% | 735,486 | +0.8% | 0.01% | -16.7% |
| Q1 2021 | $34,561,000 | -27.2% | 729,918 | -6.2% | 0.01% | -33.3% |
| Q4 2020 | $47,500,000 | +26.8% | 778,307 | -2.9% | 0.01% | +12.5% |
| Q3 2020 | $37,474,000 | -12.0% | 801,597 | -4.5% | 0.01% | -20.0% |
| Q2 2020 | $42,589,000 | +21.7% | 839,344 | +7.0% | 0.01% | 0.0% |
| Q1 2020 | $35,009,000 | -4.8% | 784,761 | +2.5% | 0.01% | +25.0% |
| Q4 2019 | $36,779,000 | +43.7% | 765,746 | +1.2% | 0.01% | +33.3% |
| Q3 2019 | $25,603,000 | -16.6% | 757,026 | +11.0% | 0.01% | -14.3% |
| Q2 2019 | $30,701,000 | +21.8% | 682,232 | +1.9% | 0.01% | +16.7% |
| Q1 2019 | $25,211,000 | +24.5% | 669,778 | +13.5% | 0.01% | 0.0% |
| Q4 2018 | $20,257,000 | -43.5% | 590,227 | -22.6% | 0.01% | -33.3% |
| Q3 2018 | $35,829,000 | +44.2% | 762,338 | +3.5% | 0.01% | +50.0% |
| Q2 2018 | $24,855,000 | +38.1% | 736,892 | +10.8% | 0.01% | +20.0% |
| Q1 2018 | $17,999,000 | +61.6% | 665,136 | -0.4% | 0.01% | +66.7% |
| Q4 2017 | $11,136,000 | -17.8% | 667,657 | -1.4% | 0.00% | -25.0% |
| Q3 2017 | $13,551,000 | +20.2% | 677,230 | +10.1% | 0.00% | +33.3% |
| Q2 2017 | $11,275,000 | +102.1% | 615,096 | +8.5% | 0.00% | +50.0% |
| Q1 2017 | $5,578,000 | -9.3% | 566,788 | +0.6% | 0.00% | 0.0% |
| Q4 2016 | $6,149,000 | -19.8% | 563,557 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $7,664,000 | +139.1% | 547,068 | +19.8% | 0.00% | +100.0% |
| Q2 2016 | $3,205,000 | +4.7% | 456,607 | +13.4% | 0.00% | 0.0% |
| Q1 2016 | $3,062,000 | -77.9% | 402,534 | -6.0% | 0.00% | -80.0% |
| Q4 2015 | $13,868,000 | +23.8% | 428,004 | +2.0% | 0.01% | +25.0% |
| Q3 2015 | $11,205,000 | -24.1% | 419,709 | +36.9% | 0.00% | 0.0% |
| Q2 2015 | $14,759,000 | -20.0% | 306,666 | +1.2% | 0.00% | -33.3% |
| Q1 2015 | $18,444,000 | +24.5% | 303,104 | +5.9% | 0.01% | +50.0% |
| Q4 2014 | $14,814,000 | +27.8% | 286,145 | +8.6% | 0.00% | 0.0% |
| Q3 2014 | $11,591,000 | +179.6% | 263,377 | +66.1% | 0.00% | +300.0% |
| Q2 2014 | $4,145,000 | +5.7% | 158,564 | +5.7% | 0.00% | 0.0% |
| Q1 2014 | $3,921,000 | +75.7% | 150,010 | +14.1% | 0.00% | 0.0% |
| Q4 2013 | $2,232,000 | +134.2% | 131,522 | +196.3% | 0.00% | – |
| Q3 2013 | $953,000 | – | 44,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |